Skip to main content
Premium Trial:

Request an Annual Quote

EGene Enters Genotyping Collaboration with University of Innsbruck

NEW YORK, Oct. 18 (GenomeWeb News) - Microfluidics developer eGene has signed a collaboration for large-scale genotyping studies with Andreas Guttman, a professor in the Horvath Laboratory of Bioseparation Sciences at the University of Innsbruck, Austria, eGene said today.

 

The collaboration will involve eGene's HAD-GT12 genetic analyzer system. eGene and Guttman's research group had previously collaborated on a study of 100 individuals of Hungarian origin for genotype frequencies for two polymorphisms in the deoxycytidine kinase gene.

 

"This collaboration agreement will allow eGene to work [more closely] with professor Guttman's laboratory on more genetic testing, including haplotyping," Ming Liu, eGene's CEO, said in a statement.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.